Results 91 to 100 of about 16,412,614 (252)

Quality and Patient Safety Division Annual Report 2014

open access: yes, 2015
A work plan is developed on an annual basis to support the quality and patient safety objectives in the National Service Plan. This report reviews the work completed in 2014 in delivery of the 2013 plan.
Quality Improvement Division
core  

The development and validation of dried blood spots for external quality assurance of syphilis serology. [PDF]

open access: yes, 2013
BACKGROUND: Syphilis causes up to 1,500,000 congenital syphilis cases annually. These could be prevented if all pregnant women were screened, and those with syphilis treated with a single dose of penicillin before 28 weeks gestation.
Todd Jim   +32 more
core   +2 more sources

Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Extracellular vesicle (EV) lipidomic profiling of plasma and ascites from patients with high‐grade serous ovarian cancer and of ovarian cancer cell lines reveals enrichment of triglycerides (TGs), diacylglycerols (DGs), phosphatidylcholine (PCs), sphingomyelins (SMs), reflecting tumor metabolic reprogramming.
Shikha Rani   +9 more
wiley   +1 more source

Deep learning for patient-specific quality assurance of volumetric modulated arc therapy: predicting gamma passing rate based on accelerator dynamic log files

open access: yesScientific Reports
To predict and classify the gamma passing rate (GPR) for patient-specific quality assurance (PSQA) in VMAT using a deep learning approach based on accelerator dynamic log files. Dynamic log files of 438 VMAT plans were analyzed.
Haihua Lei   +10 more
doaj   +1 more source

A Balanced Multimodal Multi-Task Deep Learning Framework for Robust Patient-Specific Quality Assurance

open access: yesDiagnostics
Background: Multimodal Deep learning has emerged as a crucial method for automated patient-specific quality assurance (PSQA) in radiotherapy research.
Xiaoyang Zeng   +2 more
doaj   +1 more source

APOBEC3 activity and DNA polymerase‐ε deficiency are associated with distinct IDH1 R132 hotspot mutations

open access: yesMolecular Oncology, EarlyView.
Isocitrate dehydrogenase 1 (IDH1) mutations are highly recurrent in multiple human cancer types, including cholangiocarcinoma and glioma. IDH1 R132C is the most common IDH1 mutation in cholangiocarcinoma and likely arises from APOBEC3A‐ or APOBEC3B‐mediated deamination.
Kelly E. Butler   +3 more
wiley   +1 more source

Quality assurance during system/product development [PDF]

open access: yes, 1990
Bibliography: leaves 85-86.This thesis discusses the need for and requirements of quality assurance during development of systems and products. Quality Assurance is necessary during the acquisition programme to verify that the deliverable end products ...
Schultz, Richard Wilhelm
core   +1 more source

p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer‐relevant paralog interplay

open access: yesMolecular Oncology, EarlyView.
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault   +12 more
wiley   +1 more source

A Time-Series Approach for Machine Learning-Based Patient-Specific Quality Assurance of Radiosurgery Plans

open access: yesBioengineering
Stereotactic radiosurgery (SRS) for multiple brain metastases can be delivered with a single isocenter and non-coplanar arcs, achieving highly conformal dose distributions at the cost of extreme modulation of treatment machine parameters.
Simone Buzzi   +13 more
doaj   +1 more source

Patient Specific Quality Assurance: Transition from IMRT to IMAT

open access: yesJournal of Physics: Conference Series, 2010
The purpose of this study was to test a patient-specific quality assurance (QA) protocol for intensity-modulated arc radiotherapy (IMAT), and to evaluate the use of an intensity-modulated stationary radiotherapy QA device (2D ion chamber array). Thirty-nine IMAT treatment plans for brain, spine, and prostate were analyzed using 3 methods: ion chamber ...
Jennifer O'Daniel   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy